Author:
Woyessa Delelegn,Morou Evangelia,Wipf Nadja,Dada Nsa,Mavridis Konstantinos,Vontas John,Yewhalaw Delenasaw
Abstract
Abstract
Background
Anopheles funestus, which is considered as secondary vector of malaria in Ethiopia, is known to have several morphologically indistinguishable (sibling) species. Accurate identification of sibling species is crucial to understand their biology, behaviour and vector competence. In this study, molecular identification was conducted on the Ethiopian An. funestus populations. Moreover, insecticide resistance mechanism markers were detected, including ace N485I, kdr L1014F, L1014S, and CYP6P9a TaqMan qPCR was used to detect the infective stage of the parasite from field collected adult female An. funestus populations.
Methods
Adult female mosquito collection was conducted from Lare, Gambella Regional State of Ethiopia between June 2018 to July 2020 using CDC light traps and HLC. Sub-samples of the morphologically identified An. funestus mosquitoes were molecularly identified using species-specific PCR, and the possible presence of insecticide resistance alleles was investigated using TaqMan qPCR (N485I-Ace-1), PCR-Sanger sequencing (L1014F-kdr), and PCR–RFLP (CYP6P9a resistance allele). Following head/thorax dissection, the TaqMan qPCR assay was used to investigate the presence of the infective stage Plasmodium parasite species.
Results
A total of 1086 adult female An. funestus mosquitoes were collected during the study period. All sub-samples (N = 20) that were morphologically identified as An. funestus sensu lato (s.l.) were identified as An. funestus sensu stricto (s.s.) using species- specific PCR assay. The PCR–RFLP assay that detects the CYP6P9a resistance allele that confers pyrethroid resistance in An. funestus was applied in N = 30 randomly selected An. funestus s.l. specimens. None of the specimens showed a digestion pattern consistent with the presence of the CYP6P9a resistance allele in contrast to what was observed in the positive control. Consequently, all samples were characterized as wild type. The qPCR TaqMan assay that detects the N485I acetylcholinesterase-1 mutation conferring resistance to organophosphates/carbamates in An. funestus was used in (N = 144) samples. All samples were characterized as wild type. The kdr L1014F and L1014S mutations in the VGSC gene that confer resistance to pyrethroids and DDT were analysed with direct Sanger sequencing after PCR and clean-up of the PCR products were also characterized as wild type. None of the samples (N = 169) were found positive for Plasmodium (P. falciparum/ovale/malariae/vivax) detection.
Conclusion
All An. funestus s.l. samples from Lare were molecularly identified as An. funestus s.s. No CYP6P9, N485I acetylcholinesterase 1, kdr L1014F or L1014S mutations were detected in the An. funestus samples. None of the An. funestus samples were positive for Plasmodium. Although the current study did not detect any insecticide resistant mechanism, it provides a reference for future vector monitoring programmes. Regular monitoring of resistance mechanisms covering wider geographical areas of Ethiopia where this vector is distributed is important for improving the efficacy of vector control programs.
Funder
European Union’s Horizon 2020
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference41 articles.
1. Mustapha AM, Musembi S, Nyamache AK, Machani MG, Kosgei J, Wamuyu L, et al. Secondary malaria vectors in western Kenya include novel species with unexpectedly high densities and parasite infection rates. Parasit Vectors. 2021;14:252.
2. Atkinson JM, Fitzgerald L, Toaliu H, Taleo G, Tynan A, Whittaker L, et al. Community participation for malaria elimination in Tefea Province: Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. Malar J. 2010;9:93.
3. Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, et al. Initial evidence of reduction of malaria cases and death in Rwanda and Ethiopa due to rapid scale-up of malaria prevention and treatment. Malar J. 2009;8:14.
4. WHO. World malaria report. 2015. Geneva: World Health Organization; 2015.
5. Afrane YA, Bonizzoni M, Yan G. Secondary malaria vectors of sub-Saharan Africa: threat to malaria elimination on the continent? In: Rodriguez-Morales AJ, editor. Current topics in malaria. London: IntechOpen; 2016.